Xcell Therapeutics Inc.
Develops and produces serum-free, chemically defined media for cell culture.
373110 | KO
Overview
Corporate Details
- ISIN(s):
- KR7373110006
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 강남구 영동대로 333 동원빌딩 6층, 강남구
- Website:
- https://www.xcell.co.kr/
- Sector:
- Manufacturing
Description
Xcell Therapeutics Inc. is a company specializing in the research, development, and production of advanced cell culture media. Its primary product line, CellCor™, consists of serum-free, chemically defined media designed to provide an optimal environment for cell culture, particularly for mesenchymal stem cells (MSCs). The technology aims to enhance efficiency and yield for researchers and developers in the fields of cell therapy and regenerative medicine. By offering a serum-free alternative, the company provides a more consistent and defined solution compared to traditional media. Xcell Therapeutics is also expanding its services to become a Contract Development and Manufacturing Organization (CDMO) and is exploring applications for its media in the cultured meat sector.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-07-22 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 20.8 KB | ||
| 2024-07-22 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 128.6 KB | ||
| 2024-07-19 00:00 |
임시주주총회결과
|
Korean | 10.6 KB | ||
| 2024-07-08 00:00 |
증권발행실적보고서
|
Korean | 157.0 KB | ||
| 2024-07-02 00:00 |
[발행조건확정]증권신고서(지분증권)
|
Korean | 497.3 KB | ||
| 2024-07-02 00:00 |
[기재정정]투자설명서
|
Korean | 4.0 MB | ||
| 2024-06-27 00:00 |
투자설명서
|
Korean | 3.5 MB | ||
| 2024-06-04 00:00 |
[기재정정]증권신고서(지분증권)
|
Korean | 5.6 MB | ||
| 2024-05-13 00:00 |
분기보고서 (2024.03)
|
Korean | 984.7 KB | ||
| 2024-05-13 00:00 |
증권신고서(지분증권)
|
Korean | 3.0 MB | ||
| 2024-04-03 00:00 |
주요사항보고서(유형자산양도결정)
|
Korean | 12.2 KB | ||
| 2024-03-29 00:00 |
사업보고서 (2023.12)
|
Korean | 1.1 MB | ||
| 2023-03-31 00:00 |
감사보고서 (2022.12)
|
Korean | 379.6 KB | ||
| 2023-03-31 00:00 |
연결감사보고서 (2022.12)
|
Korean | 372.9 KB | ||
| 2022-03-31 00:00 |
감사보고서 (2021.12)
|
Korean | 422.0 KB |
Automate Your Workflow. Get a real-time feed of all Xcell Therapeutics Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Xcell Therapeutics Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Xcell Therapeutics Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
